SEC Form 4 · accession 0001144204-15-067239
PALISADE BIO, INC. · PALI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Garr
Officer — CEO · Director
Period of report
Nov 19, 2015
Accepted (ET)
Nov 20, 2015 · 4:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001357459
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 19, 2015 | M | 138,122 | $0.00 | A | 1,474,243 | D | |
| Common StockF1 | Nov 19, 2015 | F | 37,776 | $1.14 | D | 1,436,467 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF2,F1 | — | Nov 19, 2015 | M | 138,122 | D | Nov 15, 2015 | — | Common Stock | 138,122 | 0 | D |
Explanation of responses
- F1Represents the conversion of restricted stock units into Common Stock. On November 19, 2015, the reporting person was granted 138,122 shares of Common Stock, of which 37,776 shares were forfeited for tax withholding purposes.
- F2Each restricted stock unit represents a right to receive one share of Neuralstem's Common Stock.